{"DataElement":{"publicId":"5839598","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Immune Status Code","preferredDefinition":"A numeric coded response for questions related to AIDS immune status.","longName":"AIDS_IMM_ST_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"5839597","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Immune Status","preferredDefinition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood._Protected against infectious disease by either specific or non-specific mechanisms._A condition or state at a particular time.","longName":"2542204v1.0:5839595v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"2542204","version":"1","preferredName":"Acquired Immunodeficiency Syndrome","preferredDefinition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes; opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis); and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. Generalized lymphadenopathy, fever, weight loss, and chronic diarrhea are common symptoms of AIDS. The patients usually die either of opportunistic infections or malignant neoplasms. -- 2004","longName":"C2851","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired Immunodeficiency Syndrome","conceptCode":"C2851","definition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"224D2D65-6714-4AEB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-15","modifiedBy":"ONEDATA","dateModified":"2006-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5839595","version":"1","preferredName":"Immune Status","preferredDefinition":"Protected against infectious disease by either specific or non-specific mechanisms.:A condition or state at a particular time.","longName":"C17997:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune","conceptCode":"C17997","definition":"Protected against infectious disease by either specific or non-specific mechanisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"50C11E85-CE94-7072-E053-F662850AD294","latestVersionIndicator":"Yes","beginDate":"2017-05-30","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-30","modifiedBy":"ONEDATA","dateModified":"2017-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"50C11E85-CEA5-7072-E053-F662850AD294","latestVersionIndicator":"Yes","beginDate":"2017-05-30","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-30","modifiedBy":"SOKKERL","dateModified":"2017-05-30","changeDescription":"5/30/2017 LS/TT  CITN-12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5839422","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Immune Status Code","preferredDefinition":"A symbol or combination of symbols which is assigned to the members of a collection.","longName":"5839422v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"CD4+ count  less than or equal to 200 cells/microliter","ValueMeaning":{"publicId":"5838507","version":"1","preferredName":"CD4+ count  less than or equal to 200 cells/microliter","longName":"5838507","preferredDefinition":"CD4+ count  less than or equal to 200 cells/microliter","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"506E3FF1-E9F4-78FF-E053-F662850A0A82","latestVersionIndicator":"Yes","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"SOKKERL","dateModified":"2020-02-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"50BED587-C037-1637-E053-F662850ADDC0","beginDate":"2017-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-05-30","modifiedBy":"ONEDATA","dateModified":"2017-05-30","deletedIndicator":"No"},{"value":"0","valueDescription":"CD4+ count greater than 200 cells/microliter","ValueMeaning":{"publicId":"5838508","version":"1","preferredName":"CD4+ count greater than 200 cells/microliter","longName":"5838508","preferredDefinition":"CD4+ count greater than 200 cells/microliter","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"506E3FF1-EA17-78FF-E053-F662850A0A82","latestVersionIndicator":"Yes","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"SOKKERL","dateModified":"2020-02-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"50BED587-C04B-1637-E053-F662850ADDC0","beginDate":"2017-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-05-30","modifiedBy":"ONEDATA","dateModified":"2017-05-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261841","version":"1","preferredName":"Code","preferredDefinition":"A system of numbered categories for representation of data.","longName":"C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-6427-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-07-13","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"50BED587-C020-1637-E053-F662850ADDC0","latestVersionIndicator":"Yes","beginDate":"2017-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-05-30","modifiedBy":"SOKKERL","dateModified":"2020-02-25","changeDescription":"5/30/17 tt/ls CITN-12.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Immune Status","type":"Preferred Question Text","description":"Immune Status","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"50C13D14-6D08-6A5C-E053-F662850A623C","latestVersionIndicator":"Yes","beginDate":"2017-05-30","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-30","modifiedBy":"SOKKERL","dateModified":"2017-05-30","changeDescription":"5/30/2017 LS/TT  CITN-12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}